Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

A machine-learning approach for monitoring the progression of Alzheimer's disease

Researchers evaluate the predictive value of a multidimensional machine learning approach for monitoring the progression of Alzheimer’s disease.

19 Jul 2023

Hearing aids may offer protection against cognitive decline in older adults at high risk of dementia

While hearing aids and audiological support services did not have any impact on cognitive decline over 3 years in a general population of older adults, treating hearing loss protected against cognitive decline in older adults at greater risk of dementia.

18 Jul 2023

MCW professor awarded $13 million NIH grant to study misplaced calcification in AMD and Alzheimer's

Francesca Marassi, PhD, professor and chair of biophysics at the Medical College of Wisconsin (MCW), has been awarded a five-year, $13 million program project grant (PPG) by the National Institutes of Health (NIH) to study misplaced calcification in the eyes and brains of patients suffering from age-related macular degeneration (AMD) and Alzheimer's disease (AD).

18 Jul 2023

Cultural and individual factors influence sleep quantity and quality

Sleep has a huge impact on health, well-being and productivity, but how long and how well people sleep these days has not been accurately reported.

18 Jul 2023

Spinal fluid test could be used for early detection of Lewy body disease

Lewy body disease is the second most common neurodegenerative disease after Alzheimer's disease. A research group from Lund University has now shown that the disease can be detected before symptoms appear, using a spinal fluid test.

18 Jul 2023

Opioids linked to increased risk of death in older adults with dementia

The study population included everyone in Denmark aged 65 and older diagnosed with dementia between Jan. 1, 2008 and Dec. 31, 2018 (n=75,471), including both home-living and nursing home residents. Of that group, 42% (31,619) of those diagnosed with dementia redeemed a prescription for an opioid at a pharmacy.

18 Jul 2023

IU researchers present groundbreaking findings at Alzheimer's conference

Researchers from Indiana University School of Medicine had a large presence and leadership role at the 2023 Alzheimer's Association International Conference in Amsterdam, Netherlands, with involvement in more than 150 presentations at the four-day meeting.

18 Jul 2023

Magnetic susceptibility as a promising marker for predicting future severity of Parkinson's disease

Researchers evaluate quantitative magnetic susceptibility mapping in detecting quantifiable markers of Parkinson’s disease progression.

18 Jul 2023

Donanemab may offer new hope for people with early Alzheimer's disease

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important advancement in Alzheimer's research and treatment.

17 Jul 2023

COVID-19 vaccines saved lives of older adults with dementia in long-term care

Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, yet remained high for those living at home, according to a new study led by UC San Francisco.

17 Jul 2023

Donanemab shows promise in slowing Alzheimer's disease

With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.

17 Jul 2023

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

Researchers compared the association between neuroimaging markers of dementia and antibodies to common infection.

17 Jul 2023

First-ever county-level estimates of Alzheimer's prevalence released at AAIC 2023

The first-ever county-level estimates of the prevalence of people with Alzheimer's dementia — in all 3,142 United States counties — were released today at the Alzheimer's Association International Conference 2023, in Amsterdam, Netherlands, and online.

17 Jul 2023

Touching lives: understanding factors for successful touch interventions

Researchers aimed to understand the impact of touch interventions on mental and physical health.

17 Jul 2023

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

Researchers conducted cerebrospinal fluid (CSF) proteome profiling and identified CSF proteins.

17 Jul 2023

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

How do neurological disorders arise that are caused, triggered, or influenced by antibodies? What better possibilities are there for diagnosis – and above all for treatment? These are the questions addressed by the new Clinical Research Unit "BecauseY" headed by Charité – Universitätsmedizin Berlin. Innovative treatment options will especially benefit patients who at first glance are not suspected of having an antibody-mediated neurological disease.

14 Jul 2023

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it has launched LucentAD, a test to assist in the evaluation of patients experiencing cognitive symptoms consistent with the early signs of Alzheimer’s disease (AD).

From Quanterix 14 Jul 2023

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

A machine-learning approach for monitoring the progression of Alzheimer's disease

Hearing aids may offer protection against cognitive decline in older adults at high risk of dementia

MCW professor awarded $13 million NIH grant to study misplaced calcification in AMD and Alzheimer's

Cultural and individual factors influence sleep quantity and quality

Spinal fluid test could be used for early detection of Lewy body disease

Opioids linked to increased risk of death in older adults with dementia

IU researchers present groundbreaking findings at Alzheimer's conference

Magnetic susceptibility as a promising marker for predicting future severity of Parkinson's disease

Donanemab may offer new hope for people with early Alzheimer's disease

COVID-19 vaccines saved lives of older adults with dementia in long-term care

Donanemab shows promise in slowing Alzheimer's disease

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

First-ever county-level estimates of Alzheimer's prevalence released at AAIC 2023

Touching lives: understanding factors for successful touch interventions

New proteomic insights: cerebrospinal fluid biomarkers show promise in detecting dementia with Lewy bodies

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

Quanterix launches LucentAD Biomarker blood test to aid physician diagnosis of Alzheimer’s disease in patients

Study suggests anxiety increases the risk of subsequent cognitive progression in non-dementia elderly

Superagers more likely to have greater movement speed than typical older adults

AI tool accurately counts brain lesions on MRI scans within seconds

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in